Pentobarbital
As of the edition of 20 October 2026, Pentobarbital is a small molecule: withdrawn from the market in 1980; acts on GABRB1, GABRB2 and GABRB3.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Withdrawn from market, 1980
- Kind
- Small molecule
- Withdrawn from market
- 1 January 1980 (in some regions)
- Registered trials
- 4, 1 stopped early
- Disease areas
- Heart and blood vessels; Injuries; Nervous system
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Targets
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 1 | 0 | 0 | 0 |
| Phase 1 | 2 | 2 | 0 | 0 |
| Phase 3 | 1 | 0 | 0 | 1 |
| All trials | 4 |